Ibandronate [ibandronic acid] with or without capecitabine in elderly patients with early breast cancer
Phase of Trial: Phase III
Latest Information Update: 13 Dec 2014
At a glance
- Drugs Capecitabine; Ibandronic acid; Ibandronic acid
- Indications Early breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ICE
- 13 Dec 2014 Results presented at the 37th Annual San Antonio Breast Cancer Symposium.
- 16 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Aug 2011 Planned End Date changed from 1 Oct 2010 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History